Welcome to the Value Driven Pharma Event

Maximize Market Share in An Era of Value Based Benefit Design

IIR's 2nd Annual Value Driven Pharma is not just another managed markets event – it is a uniquely interactive event for pharmaceutical marketing and commercialization executives to uncover what value means to payers and how to deliver outcomes, safety, and efficacy data that will maximize market share in an era of value based benefit design.

Following the successful launch of Value-Driven Pharma last year, IIR is excited to present the all new line-up for 2010 and enhanced agenda. As payers demand innovations which drive value for patients, manufacturers and payers must work together to align incentives behind improving the health of individuals. Value Driven Pharma is the one event where you can come together to achieve this common goal.

As stakeholders look to obtain market access through risk-sharing contracting models, leveraging Comparative Effectiveness Research to significantly contribute to value propositions, pharma must prepare to prove value from clinical trials all the way to formulary placement to get it right every step of the way.

The 2nd Annual Value Driven Pharma event is the only program that will prepare you to meet payer demands. Register Now to take advantage of everything VDP has to offer:

• Meet face to face with health plan and payer leaders to discuss payers' criteria for determining value and find out how health care reform will change the way health plans measure value
• Hear directly from senior executives from Pfizer, Merck, Eli Lilly, Abbott, and GSK on how to develop a robust value proposition throughout the entire lifecycle from clinical trials to post marketing studies
• Interpret the implementation of Comparative Effectiveness Research(CER) to demonstrate your product's benefit
• Learn about risk sharing contracting models like the Cigna Merck performance based pricing model and evaluate the appropriate use of outcomes based pricing agreements within your portfolio
• Develop your clinical trial dossier to demonstrate benefit and deliver expected value metrics to all stakeholders
• Understand quality measures, performance guidelines and value based purchasing
• Integrate a robust value proposition earlier in product development
• Obtain the tools to deliver solid economic health data applicable to real-world needs and decisions faced by patients, clinicians and payers necessary to obtain formulary placement
• Respond to the shifting payer mix and optimize your formulary and reimbursement strategy to ensure to reap the benefits of increased prescription volumes
• Break out of organizational silos to solidify relationships with R&D at development and throughout commercialization
• Factor subjective evaluation of objective evidence by society, patient and payer needs to determine drug value
  
  

New Interactive Format to Foster Collaboration for 2010

Benefit from over 20 hours of face-to-face working groups, networking breaks, and roundtable luncheons. Interactive topics include:

• Working Group: Reconcile Government and Patient Perspectives on Drug Valuation to Align Incentives Behind Improving Individual Health
• Focus Group: Pharma And Payer Debate On Value Delivery And Assessment To Achieve Formulary Placement
• Working Group: Develop Outcomes Based Pricing Agreements to Secure Market Share and Deliver Value to Payer Partners
• Market Insights Dinner Workshops on Data Collection, Evaluation and Reporting Strategies That Meet Plan Needs and Trial Design Strategies that Deliver the Data the Way Government & Plans Want It
  
  

Register now for Value Driven Pharma to productively respond to the changing economics of drug "value" metrics to remain competitive.

	Thomas Goetz Executive Editor, WIRED MAGAZINE, Author, The Decision Tree
	Allan Korn, MD, FACP, VP, Portfolio Management and Strategy, Global Human Health, BLUE CROSS BLUE SHIELD ASSOCIATION
	Pasquale Ceterera, Vice President, Portfolio Management and Strategy, Global Human Health, MERCK
	Catherine Melfi, PhD, Senior Director, Global Health Outcomcomcomes, ELI LILLY & CO

	Linked-in Group
	Future of Biopharma Blog
	Twitter
	Opt-In For Value Driven Pharma Updates
	Add event to Outlook
	Send to a Friend